Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies

Julian Peto | Moyses Szklo | Anthony B. Miller | Jack Cuzick | Victor Siskind | Graham A. Colditz | Chris Bain | Giske Ursin | Richard Doll | Ettore Marubini | Sylvia Richardson | Eva Negri | Eiliv Lund | Monica Ferraroni | Emily White | Mark W. Oberle | Klim McPherson | R. J. Coates | Marilie D. Gammon | Nadine Andrieu | Kathleen E. Malone | Janet L. Stanford | M. C. Pike | D. Bull | Jonas Ranstam | Robert Spirtas | Valerie Beral | Luis Rosero-Bixby | Freda E. Alexander | Leslie Bernstein | Richard P. Gallagher | Louise Jones | Stephen W. Duffy | K. Ebeling | Andrew J. Coldman | Robert A. Hiatt | V. Beral | R. Collins | M. Pike | R. Goldbohm | C. Baines | C. Wall | B. Modan | G. Colditz | J. Ranstam | S. Duffy | J. Cuzick | R. Doll | R. Peto | R. Hiatt | R. Hoover | M. Mahoney | H. Adami | P. Wingo | E. Negri | S. Franceschi | M. Szklo | J. Stanford | J. Peto | R. Coates | E. Calle | Jian-Min Yuan | R. Gallagher | H. Stalsberg | L. Brinton | I. Fentiman | R. Hanson | T. Key | L. Bernstein | J. Liff | A. Miller | C. Wongsrichanalai | P. Newcomb | R. Talamini | K. McPherson | F. Alexander | V. Siskind | G. Friedman | E. White | A. Paganini-Hill | Peter Boyle | G. Ursin | C. Bain | T. Bishop | C. Schairer | C. Taylor | David B. Thomas | H. Ory | R. Haile | G. Reeves | K. Malone | Mimi C. Yu | L. Rosero-Bixby | E. Marubini | J. Hayward | E. Clarke | M. Lê | T. Möller | M. Ewertz | R. Ross | E. Lund | C. Chilvers | C. Heath | J. Daling | P. Hannaford | H. Peterson | P. Smith | M. Gammon | H. Wilson | D. Skegg | R. Spirtas | M. Rookus | L. Jones | K. Ebeling | N. Andrieu | M. Gerber | R. Renaud | H. P. Lee | M. Primic‐Žakelj | D. Bull | D. Yeates | P. Kenya | D. Gatei | A. Coldman | P. Brandt | M. Oberle | C. Ségala | Rory Collins | Polly A. Newcomb | Robert W. Haile | Richard Peto | Jian-Min Yuan | Eugenia E. Calle | Jonathan M. Liff | N. Chantarakul | Suporn Koetsawang | L. M. Kolonel | B. Crossley | C. Hermon | Timothy J. Key | Ian S. Fentiman | Howard W. Ory | Herbert B. Peterson | P. A. Wingo | D. Kunde | P. Nishan | Tieng Pardthaisong | S. Silpisornkosol | C. Theetranont | B. Boosiri | S. Chutivongse | P. Jimakorn | Pramuan Virutamasen | C. Wongsrichanalai | Cornelia J. Baines | C. Wall | Hans-Olov Adami | Carle Paul | David C. G. Skegg | H. R. Cuevas | P. Ontiveros | A. Palet | S. B. Salazar | A. Cuadros | A. Brêmond | B. Gairard | J. Lansac | R. Renaud | Silvia Franceschi | Baruch Modan | Gary D. Friedman | M. Primic-Zakelj | B. Ravnihar | J. Stare | R. L. Hanson | M. C. Mahoney | P. C. Nasca | A. O. Varma | A. L. Weinstein | R. A. Goldbohm | P. A. van den Brandt | R. A. Apelo | J. Baens | J. R. de la Cruz | B. Javier | L. B. Lacaya | Mariette Gerber | C. Segala | D. Gatei | P. Kenya | A. Kungu | J. G. Mati | Louise A. Brinton | Robert N. Hoover | Catherine Schairer | Matti A. Rookus | J. A. Schoenberg | A. Neil | CliffordR. Kay | H. Y. Wei | T. Yun | C. Zhiheng | G. Berry | J. C. Booth | T. Jelihovsky | Robert MacLennan | Q. S. Wang | H. Stalsberg | A. Dabancens | O. Salas | F. Schofield | Annlia Paganini-Hill | R. K. Ross | Marianne Ewertz | E. A. Clarke | S. Holck | O. Meirik | Reinhold Bergström | Renato Talamini | Gillian K Reeves | J. Lansac | E. Noonan | P. Smith | F. Clavel | A. Brémond | T. Rohan | A. Nomura | Clair Chilvers | S. Koetsawang | J. R. D. L. Cruz | R. Apelo | Clark W. Heath | H. L. Miracle-McMahill | D. RachawatRachawat | A. Morabia | L. Schuman | Walter F. Stewart | P. Band | T. G. Hislop | P. Yang | Abraham M. Y. Nomura | Hoyt G. Wilson | Nicholas G. Martin | A. J. McMichael | T. Rohan | Peter Boyle | M. Evstifeeva | Janet R. Daling | E. A. Noonan | N. S. Weiss | F. Clavel | L. Piana | S. R P Fine | N. Aristizabel | A. Bachelot | M. G. Lê | J. Deacon | C. N. Taylor | E. Alfandary | Elaine Ron | T. Bishop | J. Kosmelj | W. L. Beeson | Graeme Fraser | D. S. Allen | R. D. Bulbrook | J. L. Hayward | D. Y. Wang | M. C. Leske | Torgil Möller | Håkan Olsson | Corazon A. Ngelangel | C. La Vecchia | F. V. van Leeuwen | M Vessey | D. Yeates | S. Jones | C. Lewis | P. Hannaford | Yan Gao | J. Cooper Booth | R. Shearman | L. Martinez | R. Molina | B. S. Hulka | Mimi C. Yu | M. P. Longnecker | T. M N Farley | N. Chantarakul | A. Morabia | L. Schuman | W. Stewart | F. Schofield | P. Band | T. Hislop | P. Yang | D. Kunde | P. Nishan | N. Martin | T. Pardthaisong | S. Silpisornkosol | C. Theetranont | B. Boosiri | S. Chutivongse | P. Jimakorn | P. Virutamasen | C. Paul | M. Evstifeeva | B. Gairard | L. Piana | S. Fine | P. Ontiveros | A. Palet | N. Aristizabel | A. Cuadros | A. Bachelot | J. Deacon | E. Alfandary | Elaine Ron | J. Kosmelj | B. Ravnihar | J. Stare | G. Fraser | R. Bulbrook | D. Wang | P. Nasca | A. Varma | A. Weinstein | Hampus Olsson | J. Baens | B. Javier | L. Lacaya | C. Ngelangel | M. Ferraroni | S. Richardson | A. Kungu | J. Schoenberg | A. Neil | M. Vessey | B. Crossley | C. Hermon | S. Jones | C. Lewis | C. Kay | H. Wei | T. Yun | C. Zhiheng | G. Berry | T. Jelihovsky | R. Maclennan | R. Shearman | A. Dabancens | L. Martínez | R. Molina | O. Salas | B. Hulka | T. Farley | S. Holck | O. Meirik | D. Allen | N. Weiss | Reinhold Bergström | H. Miracle-McMahill | D. RachawatRachawat | L. Kolonel | A. Mcmichael | C. L. Vecchia | F. V. Leeuwen | Yan Gao | D. Thomas | M. Yu | P. Boyle | M. Leske | P. Smith | Graeme Fraser | Carle Paul | M. Longnecker | J. K. Mati

[1]  J. Stanford,et al.  Oral contraceptive use and risk of breast cancer in middle-aged women. , 1996, American journal of epidemiology.

[2]  M. C. Leske,et al.  Breast cancer and hormonal contraceptives: further results , 1996 .

[3]  Karen Steindorf,et al.  Results of a case-control study on previous infections and other risk factors for ischemic cerebrovascular diseases: attributable and absolute risks , 1996, GMDS.

[4]  S. Shapiro,et al.  Case-control study of oral contraceptive use and risk of breast cancer. , 1996, American journal of epidemiology.

[5]  D. Amadori,et al.  Oral contraceptives and breast cancer: A cooperative Italian study , 2006, International journal of cancer.

[6]  P. Boyle,et al.  Breast‐cancer risk and oral contraceptive use in slovenian women aged 25 to 54 , 1995, International journal of cancer.

[7]  R. Hoover,et al.  Oral contraceptives and breast cancer risk among younger women. , 1995, Journal of the National Cancer Institute.

[8]  F. Leeuwen,et al.  Oral contraceptives and risk of breast cancer in women aged 20-54 years , 1994, The Lancet.

[9]  N. Weiss,et al.  Breast cancer among young U.S. women in relation to oral contraceptive use. , 1994, Journal of the National Cancer Institute.

[10]  W. Willett,et al.  Lactation and a reduced risk of premenopausal breast cancer. , 1994, The New England journal of medicine.

[11]  M. Thun,et al.  Family history, age, and risk of fatal breast cancer. , 1993, American journal of epidemiology.

[12]  C. la Vecchia,et al.  Oral contraceptives and breast cancer in northern Italy. Final report from a case-control study. , 1993, British Journal of Cancer.

[13]  M. Szklo,et al.  Consistent lack of association between breast cancer and oral contraceptives using either hospital or neighborhood controls. , 1993, Preventive medicine.

[14]  S. Shapiro,et al.  A case-control study of the risk of breast cancer in relation to oral contraceptive use. , 1992, American journal of epidemiology.

[15]  A. Miller,et al.  Canadian National Breast Screening Study: 1. Breast cancer detection and death rates among women aged 40 to 49 years. , 1992, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[16]  B. Henderson,et al.  A case-control study of breast cancer in Tianjin, China. , 1992, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[17]  W. Thompson,et al.  Oral Contraceptives and Premenopausal Bilateral Breast Cancer: A Case-Control Study , 1992, Epidemiology.

[18]  M. Ewertz.  Oral contraceptives and breast cancer risk in Denmark. , 1992, European journal of cancer.

[19]  Early Breast Cancer Trialists' Collaborative Group.  Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy 133 randomised trials involving 31 000 recurrences and 24 000 deaths among 75 000 women , 1992, The Lancet.

[20]  M. Gerber,et al.  The pattern of risk factors for breast cancer in a southern France population. Interest for a stratified analysis by age at diagnosis. , 1991, British Journal of Cancer.

[21]  M. C. Leske,et al.  Breast cancer risk and oral contraceptive use: results from a large case-control study. , 1991, Epidemiology.

[22]  A G Babiker,et al.  Floating absolute risk: an alternative to relative risk in survival and case-control analysis avoiding an arbitrary reference group. , 1991, Statistics in medicine.

[23]  G. Breart,et al.  Oral contraceptives and breast cancer: a French case-control study. , 1991, International journal of epidemiology.

[24]  B. Hulka,et al.  Oral contraceptives and breast cancer: A case‐control study with hospital and community controls , 1990, Obstetrics and gynecology.

[25]  E. Wynder,et al.  Oral contraceptives and breast cancer risk: a case-control study. , 1990, International journal of epidemiology.

[26]  The Who Collaborative Study of Neoplasia and Steroid Contraceptives.  Breast cancer and combined oral contraceptives: results from a multinational study , 1990 .

[27]  L. Bernstein,et al.  Update of the Los Angeles Study of oral contraceptives and breast cancer: 1981 and 1983. , 1990 .

[28]  W. Willett,et al.  Prospective study of oral contraceptive use and risk of breast cancer in women. , 1989, Journal of the National Cancer Institute.

[29]  R. Hoover,et al.  Oral contraceptives and breast cancer: results from an expanded case-control study. , 1989, British Journal of Cancer.

[30]  W. L. Beeson,et al.  Prospective study of exogenous hormone use and breast cancer in seventh‐day adventists , 1989, Cancer.

[31]  J. Ranstam,et al.  Early oral contraceptive use and breast cancer among premenopausal women: final report from a study in southern Sweden. , 1989, Journal of the National Cancer Institute.

[32]  Uk National Case-Control Study Group.  ORAL CONTRACEPTIVE USE AND BREAST CANCER RISK IN YOUNG WOMEN , 1989, The Lancet.

[33]  K. McPherson,et al.  Oral contraceptives and breast cancer: latest findings in a large cohort study. , 1989, British Journal of Cancer.

[34]  M. Pike,et al.  Oral contraceptive use and breast cancer risk in young women. , 1989 .

[35]  T. Rohan,et al.  Oral contraceptive agents and breast cancer: a population‐based case‐control study , 1988, The Medical journal of Australia.

[36]  P. Hannaford,et al.  Breast cancer and the pill--a further report from the Royal College of General Practitioners' oral contraception study. , 1988, British Journal of Cancer.

[37]  R. Brownson,et al.  Risk of breast cancer in relation to cigarette smoking. , 1988, Archives of internal medicine.

[38]  B. Henderson,et al.  Risk factors for breast cancer in Chinese women in Shanghai. , 1988, Cancer research.

[39]  U. Pastorino,et al.  The relationship of dietary intake and serum levels of retinol and beta‐carotene with breast cancer. Results of a case‐control study , 1988, Cancer.

[40]  K. Kosmelj,et al.  A case-control study of breast cancer in relation to oral contraceptive use in Slovenia. , 1988, Neoplasma.

[41]  L. Rosero-Bixby,et al.  A case-control study of breast cancer and hormonal contraception in Costa Rica. , 1987, Journal of the National Cancer Institute.

[42]  A. W. Asscher.  Oral contraceptives and breast cancer. , 1987, British Journal of Cancer.

[43]  R. Doll,et al.  Early oral contraceptive use and breast cancer: results of another case-control study. , 1987, British Journal of Cancer.

[44]  I. Fentiman,et al.  The relationship between blood prolactin levels and risk of breast cancer in premenopausal women. , 1987, European journal of cancer & clinical oncology.

[45]  A. Huggins,et al.  Risk factors for breast cancer with applications to selection for the prevalence screen. , 1987, Journal of epidemiology and community health.

[46]  H. Adami,et al.  ORAL CONTRACEPTIVE USE AND BREAST CANCER IN YOUNG WOMEN A Joint National Case-control Study in Sweden and Norway , 1986, The Lancet.

[47]  L. Kolonel,et al.  The association of replacement estrogens with breast cancer , 1986, International journal of cancer.

[48]  J. Elwood,et al.  Childhood and recent eating patterns and risk of breast cancer. , 1986, Cancer detection and prevention.

[49]  C. la Vecchia,et al.  Reproductive and hormonal factors and breast cancer in a Northern Italian population. , 1985, International journal of epidemiology.

[50]  R. Hiatt,et al.  Exogenous estrogen and breast cancer after bilateral oophorectomy , 1984, Cancer.

[51]  M. Pike,et al.  BREAST CANCER IN YOUNG WOMEN AND USE OF ORAL CONTRACEPTIVES: POSSIBLE MODIFYING EFFECT OF FORMULATION AND AGE AT USE , 1983, The Lancet.

[52]  R. Doll,et al.  Oral contraceptives and breast cancer: final report of an epidemiological study. , 1983, British Journal of Cancer.

[53]  Breast cancer and oral contraceptive use: a case-control study. , 1983, Journal of chronic diseases.

[54]  N. Weiss,et al.  Breast cancer in relation to patterns of oral contraceptive use. , 1982, American journal of epidemiology.

[55]  Vessey Mp.  The Walnut Creek contraceptive drug study. , 1981 .

[56]  B. Henderson,et al.  A case-control study of menopausal estrogen therapy and breast cancer. , 1980, JAMA.

[57]  J. Lindtner,et al.  An epidemiologic study of breast cancer and benign breast neoplasias in relation to the oral contraceptive and estrogen use. , 1979, European journal of cancer.

[58]  S. Stellman,et al.  The epidemiology of breast cancer in 785 united states caucasian women , 1978, Cancer.

[59]  J. Kelsey,et al.  Oral contraceptives and breast disease. An epidemiological study. , 1978, American journal of epidemiology.

[60]  J. Tonascia,et al.  Exogenous hormones, reproductive history, and breast cancer. , 1977, Journal of the National Cancer Institute.

[61]  J. Kampert,et al.  Cancer risk as related to use of oral contraceptives during fertile years , 1977, Cancer.

[62]  M. Pike,et al.  Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. , 1977, British Journal of Cancer.

[63]  P. Armitage,et al.  Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design. , 1976, British Journal of Cancer.

[64]  N. Mantel.  Evaluation of survival data and two new rank order statistics arising in its consideration. , 1966, Cancer chemotherapy reports.